Please refer to part A for the abstract.
Please refer to part A for the abstract.
Please refer to part A for the abstract.
Please refer to part A for the abstract.
Abstract: See Advanced Drug Delivery Systems: ALZA and Ciba-Geigy (A) - (F).
Abstract: See Advanced Drug Delivery Systems: ALZA and Ciba-Geigy (A) - (F).
Please refer to part A for the abstract.
Please refer to part A for the abstract.
Please refer to part A for the abstract.
Please refer to part A for the abstract.
Please refer to part A for the abstract.
Please refer to part A for the abstract.
The case describes the development and carry-through of strategies to increase company profitability within the semi-conductor industry.
The case describes the development and carry-through of strategies to increase company profitability within the semi-conductor industry.
The marketing manager of Ciba-Geigy's Agro Division in France must recommend a marketing strategy and marketing mix for a new fungicide. The degree of market coverage and whether to take an undifferentiated or a differentiated approach are the major issues.
The marketing manager of Ciba-Geigy's Agro Division in France must recommend a marketing strategy and marketing mix for a new fungicide. The degree of market coverage and whether to take an undifferentiated or a differentiated approach are the major issues.
This is the fourth case in a series of 11, which deals with a technological partnership between a large firm (Ciba-Geigy) and a small firm (Alza). It covers a period of about eight years: from 1977 until 1984. The first cases describe the pharmaceutical industry, the two companies, and the events leading up to the partnership opportunity.
This is the fourth case in a series of 11, which deals with a technological partnership between a large firm (Ciba-Geigy) and a small firm (Alza). It covers a period of about eight years: from 1977 until 1984. The first cases describe the pharmaceutical industry, the two companies, and the events leading up to the partnership opportunity.
This is the fifth case in a series of 11, which deals with a technological partnership between a large firm (Ciba-Geigy) and a small firm (Alza). It covers a period of about eight years: from 1977 until 1984. The first cases describe the pharmaceutical industry, the two companies, and the events leading up to the partnership opportunity.
This is the fifth case in a series of 11, which deals with a technological partnership between a large firm (Ciba-Geigy) and a small firm (Alza). It covers a period of about eight years: from 1977 until 1984. The first cases describe the pharmaceutical industry, the two companies, and the events leading up to the partnership opportunity.
Inspired by C.K. Prahalad’s “The Fortune at the Bottom of the Pyramid”, Novartis was exploring ways to build a sustainable business for the BOP in India that would improve access to healthcare for the poor while being financially profitable, unlike Novartis's traditional philanthropic and corporate social responsibility approaches.
Inspired by C.K. Prahalad’s “The Fortune at the Bottom of the Pyramid”, Novartis was exploring ways to build a sustainable business for the BOP in India that would improve access to healthcare for the poor while being financially profitable, unlike Novartis's traditional philanthropic and corporate social responsibility approaches.
Pharmaceuticals, New Product Development and Innovation, Marketing Management
